search icon
  • Print
  • ShareThis
  • Text Size
  • Federal Funding for Infectious Diseases Programs


    Today’s investment in ID research; public health and prevention; and development of new drugs, vaccines and diagnostics will pay significant dividends in the future. Such investments can prevent needless deaths, dramatically reduce health care costs, and improve the quality of life for millions of Americans and others around the world.  IDSA supports appropriate funding for domestic and international programs including those at the:

    • National Institute for Allergies and Infectious Diseases 
    • Centers for Disease Control and Prevention  
    • Food and Drug Administration 
    • Health Resources Services Administration 
    • U.S. Agency for International Development 
    • National Institute of Health’s Fogarty International Center 


    IDSA’s funding priorities include antimicrobial resistance; immunizations; drug, vaccine and diagnostics development; and HIV/AIDS and tuberculosis prevention and treatment.


    See also:

    HIVMA Federal Funding

    IDSA's Efforts in Advocating for Appropriate Federal Funding for Infectious Diseases Programs


    Need for Antibiotic Resistance Funding Featured in Testimony on FY 2016 (PDF)

    IDSA provided testimony on 2016 funding for infectious diseases priorities to the House subcommittee that has oversight of health spending. The need for funding to implement the National Action Plan for Combating Antibiotic-Resistant Bacteria was featured in the statement.

    IDSA Engages the Senate on 2016 Infectious Diseases Funding Needs (PDF)

    IDSA provided testimony to the Senate panel that oversees federal spending on health programs. The statement encouraged the subcommittee to invest in areas such as antibiotic resistance, rapid diagnostics, immunizations, global health, and neglected tropical diseases.

    IDSA Provides Testimony for Senate Hearing on Ebola Funding (PDF)

    IDSA provided testimony to the Senate Appropriations Committee in support of President Obama's request for emergency funds to deal with the Ebola outbreak.  The Committee solicited stakeholder input ahead of a hearing to discuss the President's request.

    IDSA Provides Testimony on Innovation to the Senate (PDF)

    In preparation for a Senate hearing on the federal role in promoting innovation, IDSA provided testimony on the health and economic gains possible from new public health strategies, vaccines, antibiotics, and rapid diagnostics.

    Groups Ask Leaders of Congressional Spending Panels to Increase Investments in Public Health Preparedness (PDF)

    IDSA joined several other health groups in letters to leaders of the House and Senate panels that oversee health spending urging that programs critical to public health preparedness be provided additional support in the FY 2016 appropriations process.

    IDSA Joins Groups in Effort to Retain HHS Extramural Salary Cap (PDF)

    IDSA joined 174 other groups in a letter to House and Senate Appropriations Committee leaders asking that the Health and Human Services extramural researcher salary cap be maintained at Executive Level II instead of reduced as proposed in the House.

    IDSA Joins Groups in Highlighting Importance of Federal Employee Participation in Scientific Conferences (PDF)

    IDSA joined 83 other groups in a letter to Senate appropriators expressing thanks for their recognition of the importance of federally employed scientist being able to attend mission-relevant scientific and technical conferences.

    Stakeholder Groups Share Recommendations on Global and Domestic TB Funding (PDF)

    IDSA joined several other health groups in a letter urging the White House Office of Management and Budget to place high priority on funding for global and domestic tuberculosis programs as the Fiscal Year 2017 President's budget request is prepared.

    Groups Seek Support for Global TB Activities in Anticipation of FY2014 Funding Bill Release (PDF)

    IDSA joined other stakeholders in a letter to Congress seeking $236 million for USAID's TB programs in FY2014.  The letter discusses the impact of TB around the globe and makes special note of the emergence of multidrug-resistant and extensively drug-resistant TB.  USAID is a central partner in efforts to control TB in the world's 30 most highly burdened countries.

    Community Letter Advocating Robust Global Health Efforts (PDF)

    IDSA joined 53 other organizations to urge lawmakers to maintain its funding commitments to improving health in developing countries, without cutting other broader humanitarian efforts and development or imposing any new policy restrictions.

    TB Coalition Letter for Global and Domestic TB Funding (PDF)

    IDSA joined 16 other organizations to urge lawmakers to strengthen U.S. leadership in the fight against TB as envisioned in the Lantos-Hyde Act and Comprehensive TB Elimination Act by investing in global and domestic TB programs at USAID and CDC.


Average 0 out of 5

| HIVMA | Contact Us

© Copyright IDSA 2015 Infectious Diseases Society of America

Full Site Mobile Site